SightfileU.S. market data from official filings

Companies › MDXG

MIMEDX GROUP INC (MDXG)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001376339 · EDGAR filings · Updated 2026-07-07

MIMEDX GROUP INC (MDXG) has reported institutional ownership of 75.8%, with 235 institutional managers holding positions valued at $446.1M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
75.8%
Institutional managers
235
Reported 13F value
$446.1M
Insider activity
29 trans.
$835.4K net buying
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, MIMEDX GROUP INC has 235 institutional holders and institutional ownership of 75.8%.

Insider activity

Insiders reported 29 transactions (1 buys, 1 sells) across 12 reporting insiders, with a net reported value of $835.4K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2020-07-06 (recurring since 2020-03-17) — source filing. The authoritative details are those stated in the filing itself.

Related companies

CRESCENT BIOPHARMA INC. (CBIO) · LEXEO THERAPEUTICS INC (LXEO) · INMODE LTD (INMD) · ALLOGENE THERAPEUTICS INC (ALLO) · MANNKIND CORP (MNKD) · ETON PHARMACEUTICALS INC (ETON)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-07.